HS 292214 Dextropropoxyphene (INN) and its salts
Quick Answer: HS code 292214 specifically covers Dextropropoxyphene (INN) and its salts. Dextropropoxyphene is an opioid analgesic, meaning it's a pain-relieving medication derived from opium. This classification includes the pure chemical compound and its various salt forms. For importers and exporters, understanding the duty rates is crucial. In the UK and EU, the standard duty rate for this product is 0.00% ad valorem, as per the UK Trade Tariff and EU TARIC. The US offers a "Free" duty rate under the Harmonized Tariff Schedule (HTS), but also lists a column 2 rate of 15.4¢/kg + 119.5% ad valorem, applicable to goods from non-MFN countries. Due to its nature as a controlled substance, trade in Dextropropoxyphene is subject to stringent international and national regulations, including licensing and import/export permits, beyond standard customs procedures. Importers and brokers must verify compliance with drug control laws in all relevant jurisdictions.
What Are the Import Duty Rates?
🇬🇧 United Kingdom
| Code | MFN | Preferential | Unit |
|---|---|---|---|
| 2922140000 | 0.00 % | — | — |
🇪🇺 European Union (TARIC)
| Code | MFN | Preferential | Unit |
|---|---|---|---|
| 2922140000 | 0.00 % | — | — |
🇺🇸 United States (HTSUS)
| Code | MFN | Preferential | Unit |
|---|---|---|---|
| 2922140000 | Free | — | ["kg"] |
Duty rates sourced from the USITC (US International Trade Commission) Harmonized Tariff Schedule (HTS) (accessed 2/22/2026), EU TARIC – DG TAXUD (Directorate-General for Taxation and Customs Union) (accessed 2/22/2026), and UK Trade Tariff – HMRC (His Majesty's Revenue and Customs) (accessed 2/22/2026).
Data compiled and presented by HSRates.
How to Classify This HS Code?
What products does HS 292214 cover?
This subheading covers dextropropoxyphene (INN) and its salts, which are specifically identified as amino-alcohols, other than those containing more than one type of oxygen function, and their ethers and esters, excluding those with more than one type of oxygen function. Dextropropoxyphene is an opioid analgesic, and its classification here aligns with the World Customs Organization (WCO) Harmonized System Nomenclature, which places specific chemical compounds and their derivatives under precise subheadings within Chapter 29. Official definitions from the USITC Harmonized Tariff Schedule (HTS) and the EU TARIC system confirm this specific chemical identity, ensuring consistent global classification for this controlled substance.
What falls outside HS 292214?
The following products are excluded from HS 292214: other amino-alcohols, their ethers and esters, and their salts that are not dextropropoxyphene (INN). For instance, other amino-alcohols like ethanolamine (2922.11) or diethanolamine (2922.12) are classified in their respective subheadings. Similarly, preparations containing dextropropoxyphene, such as pharmaceutical formulations for retail sale, would typically be classified in Chapter 30 (Pharmaceutical products), specifically under headings like 3004, rather than as the pure chemical substance in Chapter 29. This distinction is crucial for accurate tariff application and regulatory compliance, as Chapter 29 is reserved for isolated chemical compounds of defined chemical purity.
What are common classification mistakes for HS 292214?
A common error is misclassifying pharmaceutical preparations containing dextropropoxyphene under HS 292214 instead of Chapter 30. Importers sometimes overlook the distinction between pure chemical compounds and formulated medicines. According to General Interpretative Rule (GRI) 3(b), goods put up in sets for retail sale, or mixtures and composite goods, are classified by the component that gives them their essential character. For pharmaceutical products, this often means classification under Chapter 30, even if the active pharmaceutical ingredient (API) is a chemical from Chapter 29. Another mistake is confusing dextropropoxyphene with other opioid analgesics or similar chemical structures, leading to incorrect subheading assignment within Chapter 29 or even other chapters.
How should importers classify products under HS 292214?
The correct procedure for classifying products under HS 292214 involves first confirming the precise chemical identity of the substance as dextropropoxyphene (INN) or one of its salts, typically through a Certificate of Analysis (CoA) or chemical specification sheet. Importers and customs brokers should then apply General Interpretative Rule 1, which states that classification is determined according to the terms of the headings and any relative section or chapter notes. It is imperative to ensure the product is the pure chemical compound, not a pharmaceutical preparation, which would fall under Chapter 30. Consulting the WCO Explanatory Notes for Heading 2922 and relevant national tariff schedules (e.g., USITC HTS, EU TARIC) is also critical to confirm the specific inclusion of dextropropoxyphene and its salts within this subheading.
Which HS Codes Are Related?
Not the right code? Search all HS codes to find the correct tariff classification.
FAQ
What are the typical import duty rates for HS code 2922.14 (Dextropropoxyphene (INN) and its salts) in major markets?
The import duty rates for HS 2922.14 can vary significantly by country and trade agreement. For instance, in the United States, the Most Favored Nation (MFN) duty rate is typically 'Free' (0.00% ad valorem) under the Harmonized Tariff Schedule of the United States (HTSUS). The European Union's TARIC database generally shows a '0.00 %' ad valorem duty rate for MFN imports. However, it is crucial to verify the specific duty rate applicable to your country of import, as some nations may apply different rates, potentially including specific duties or higher ad valorem rates, particularly if the product is deemed sensitive or subject to specific trade policy measures. Always consult the official tariff schedule of the importing country (e.g., USITC HTSUS, EU TARIC, UK Trade Tariff) for the most accurate and up-to-date information.
What are the key classification criteria for Dextropropoxyphene and its salts under HS 2922.14?
HS 2922.14 specifically covers 'Dextropropoxyphene (INN) and its salts'. The classification hinges on the chemical identity of the substance. 'INN' stands for International Nonproprietary Name, which is a unique, globally recognized name assigned by the World Health Organization (WHO) to pharmaceutical substances. Therefore, for a product to be classified under 2922.14, it must be chemically identified as Dextropropoxyphene or one of its chemically defined salts (e.g., Dextropropoxyphene hydrochloride). Importers and customs brokers should ensure that the chemical name on the product's Certificate of Analysis (CoA) or safety data sheet (SDS) precisely matches the description for this subheading. Any derivatives or mixtures where Dextropropoxyphene is not the primary active ingredient or where it is combined in a specific dosage form might fall under different subheadings, such as those for medicaments of heading 3004, depending on their composition and intended use.
Are there any specific documentation requirements or regulatory controls for importing Dextropropoxyphene (INN) and its salts due to its nature?
Yes, Dextropropoxyphene is an opioid analgesic and is subject to strict international and national controls as a controlled substance. It is listed in Schedule II of the United Nations Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol. Consequently, importers will face significant documentation and regulatory requirements. This typically includes, but is not limited to: import licenses/permits issued by the national competent authority (e.g., Drug Enforcement Administration (DEA) in the US, national health ministries in other countries), detailed declarations of the substance's quantity and intended use, and compliance with specific storage, handling, and reporting requirements. Customs brokers must verify that the importer holds all necessary permits prior to shipment and that all documentation precisely matches the imported goods to avoid severe penalties, including seizure of goods and criminal charges. Consult the national drug control authority of both the exporting and importing countries for precise requirements.
How do common trade agreements, such as FTAs, affect the duty rates for HS 2922.14?
Free Trade Agreements (FTAs) and other preferential trade programs can significantly reduce or eliminate duties for HS 2922.14, provided the goods meet the specific Rules of Origin (ROO) of the respective agreement. For example, under agreements like the USMCA (United States-Mexico-Canada Agreement) or various EU FTAs, Dextropropoxyphene and its salts originating from a partner country may qualify for a 0.00% preferential duty rate. To claim preferential treatment, importers must typically provide a valid Certificate of Origin or an origin declaration from the exporter, confirming that the product meets the ROO criteria (e.g., wholly obtained, change in tariff classification, regional value content). It is essential to understand that even with an FTA, the regulatory controls for controlled substances (import permits, etc.) remain fully applicable and are separate from duty rate considerations. Always verify the specific FTA's ROO and documentation requirements for HS 2922.14.